World's Best Scientists 2026 revealed!
Award Badge
Best Female Scientists
2025

D-Index & Metrics

Best Female Scientists

D-Index
112
Citations
49233
World Ranking
808
National Ranking
491

Medicine

D-Index
113
Citations
51469
World Ranking
4917
National Ranking
2663

Research.com Recognitions

  • 2025 - Research.com Best Female Scientists Award

Overview

Madeleine Duvic is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on medicine with a considerable emphasis on dermatology, pathology and forensic medicine, epidemiology, oncology, and immunology.

The main topics covered in their work include cutaneous lymphoproliferative disorders research, lymphoma diagnosis and treatment, CAR-T cell therapy research, T-cell and retrovirus studies, fungal infections and studies, nail diseases and treatments, as well as autoimmune and inflammatory disorders.

Key recent papers authored or coauthored by Madeleine Duvic include:

  • Primary cutaneous lymphoma: recommendations for clinical trial design and staging update from the ISCL, USCLC, and EORTC, 2021, Blood
  • Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options, 2021, American Journal of Clinical Dermatology
  • New Practical Aspects of Sweet Syndrome, 2022, American Journal of Clinical Dermatology
  • Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data, 2021, Blood Advances
  • Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis, 2021, European Journal of Cancer

Frequent coauthors who have contributed significantly to research alongside Madeleine Duvic include Auris Huen, Tejas P. Joshi, Youn H. Kim, Larisa J. Geskin, and Carlos A. Torres-Cabala.

Madeleine Duvic's work has been published notably in several scientific venues, reflecting their engagement in dermatological and oncological research. Frequent publication venues include:

  • Journal of the American Academy of Dermatology
  • European Journal of Cancer
  • Blood
  • American Journal of Clinical Dermatology
  • Clinical Lymphoma Myeloma & Leukemia

Best Publications

  • Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC).

    Elise Olsen;Eric Vonderheid;Nicola Pimpinelli;Rein Willemze

  • Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

    Madeleine Duvic;Rakshandra Talpur;Xiao Ni;Chunlei Zhang

  • Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma

    Elise A. Olsen;Youn H. Kim;Timothy M. Kuzel;Theresa R. Pacheco

  • Bexarotene Is Effective and Safe for Treatment of Refractory Advanced-Stage Cutaneous T-Cell Lymphoma: Multinational Phase II-III Trial Results

    Madeleine Duvic;Kenneth Hymes;Peter Heald;Debra Breneman

  • Genome-wide association study in alopecia areata implicates both innate and adaptive immunity

    Lynn Petukhova;Madeleine Duvic;Maria Hordinsky;David Norris

  • Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.

    Elise A. Olsen;Sean Whittaker;Youn H. Kim;Madeleine Duvic

  • Final Results From a Multicenter, International, Pivotal Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma

    Sean J. Whittaker;Marie-France Demierre;Ellen J. Kim;Alain H. Rook

  • Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma

    Elise Olsen;Madeleine Duvic;Arthur Frankel;Youn Kim

  • Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas.

    Eric C. Vonderheid;Maria Grazia Bernengo;Günter Burg;Madeleine Duvic

  • Phase 2 and 3 Clinical Trial of Oral Bexarotene (Targretin Capsules) for the Treatment of Refractory or Persistent Early-Stage Cutaneous T-Cell Lymphoma

    Madeleine Duvic;Ann G. Martin;Youn Kim;Elise Olsen

  • Guidelines of care for the management of primary cutaneous melanoma

    Christopher K. Bichakjian;Allan C. Halpern;Timothy M. Johnson;Antoinette Foote Hood

  • Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

    H Miles Prince;H Miles Prince;Youn H Kim;Steven M Horwitz;Reinhard Dummer

  • European Organization for Research and Treatment of Cancer and International Society for Cutaneous Lymphoma consensus recommendations for the management of cutaneous B-cell lymphomas.

    Nancy J. Senff;Evert M. Noordijk;Youn H. Kim;Martine Bagot

  • EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma

    Werner Kempf;Katrin Pfaltz;Maarten H. Vermeer;Antonio Cozzio

  • Mortality Risk From Squamous Cell Skin Cancer

    Gary L. Clayman;J. Jack Lee;F. Christopher Holsinger;Xian Zhou

  • Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma.

    Madeleine Duvic;Jenny Vu

  • Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model

    Julia J. Scarisbrick;H. Miles Prince;Maarten H. Vermeer;Pietro Quaglino

  • Tazarotene-induced Gene 2 (TIG2), a Novel Retinoid-Responsive Gene in Skin

    Sunil Nagpal;Sheetal Patel;Heidi Jacobe;Daniel DiSepio

  • Transformation of Mycosis Fungoides/Sezary Syndrome: Clinical Characteristics and Prognosis

    Eleni Diamandidou;Maria Colome-Grimmer;Luis Fayad;Madeleine Duvic

  • Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm

    Naveen Pemmaraju;Andrew A. Lane;Kendra L. Sweet;Anthony S. Stein

Frequent Co-Authors

Youn H. Kim
Youn H. Kim Stanford University
Victor G. Prieto
Victor G. Prieto The University of Texas MD Anderson Cancer Center
Sean Whittaker
Sean Whittaker King's College London
Dan Jones
Dan Jones The Ohio State University
Timothy M. Kuzel
Timothy M. Kuzel Rush University Medical Center
Qingyi Wei
Qingyi Wei Duke University
Reinhard Dummer
Reinhard Dummer University of Zurich
H. Miles Prince
H. Miles Prince Peter MacCallum Cancer Centre
Jeffrey E. Gershenwald
Jeffrey E. Gershenwald The University of Texas MD Anderson Cancer Center
Jeffrey E. Lee
Jeffrey E. Lee The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens up a wide range of related online degrees and career pathways. If you’re interested in the business side of healthcare, pursuing a masters in healthcare administration cost can be a smart investment, with affordable programs now available to suit different budgets.

Nursing professionals seeking advanced roles may consider the cheapest bsn to dnp programs online. These programs prepare students for leadership and specialized clinical positions without putting financial strain on working nurses.

If pharmacy is your passion, you can now access flexible online pharmacy schools that help you earn your degree while balancing work and personal commitments.

Finally, those interested in the digital transformation of healthcare can check out online health information management degree programs, which prepare you to manage sensitive patient data and navigate evolving healthcare technologies.

These diverse online options can help you shape a medical career that fits your interests, schedule, and budget.

Best Scientists Citing Madeleine Duvic

Trending Scientists